Metraipolis › archive › dc_27dfaf2d32d0
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab — Europe PMC PMID:41488677
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41488677
- DOI
- 10.3389/fimmu.2025.1634477
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T13:39:33.905Z
- SHA-256 of the archived text
b49773486445c558784f70250c1886be03d2521673ddf23b9ab4002682f98114- Stable URL of this page
https://metraipolis.com/documento/dc_27dfaf2d32d0
How to cite
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab — Europe PMC PMID:41488677 — Europe PMC (en), https://europepmc.org/article/MED/41488677 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27dfaf2d32d0 (Metraipolis archive dc_27dfaf2d32d0, sha256 b49773486445c558784f70250c1886be03d2521673ddf23b9ab4002682f98114)
BibTeX
@misc{dc27dfaf2d32d0,
title = {Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab — Europe PMC PMID:41488677},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41488677},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27dfaf2d32d0; sha256 b49773486445c558784f70250c1886be03d2521673ddf23b9ab4002682f98114},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488677. Agents can read the archived copy with the MCP tool read_document.